NEW YORK, May 14, 2026, 18:01 EDT
- NANO Nuclear wrapped up March holding $568.7 million across cash, cash equivalents, and short-term investments.
- KRONOS MMR is still going through the U.S. Nuclear Regulatory Commission’s acceptance review.
- The stock jumped roughly 2%, trading at $27.54 following the company’s update.
NANO Nuclear Energy Inc. trimmed its quarterly loss and ended the period with roughly $568.7 million in cash, cash equivalents and short-term investments. That pile gives the development-stage nuclear player significant financial breathing room as it pushes ahead with efforts to get its KRONOS microreactor built.
The rush into nuclear names linked to AI data centers has picked up, but the real sticking point hasn’t changed: can these reactors actually make it through licensing, construction, and into buyers’ hands before investors lose interest. Microreactors, for their part, are designed as compact nuclear units, sited near customers instead of delivering at the scale of full-size plants.
NANO’s flagship project, KRONOS MMR, is linked to a University of Illinois Urbana-Champaign initiative aiming to build a research reactor on campus. The Nuclear Regulatory Commission noted the university filed its construction permit application on March 31; the agency’s acceptance review hasn’t wrapped up yet.
NANO is targeting a roughly 12-month review from the NRC once its application clears the formal acceptance stage, so initial construction could kick off sometime between mid and late 2027. The company also wrapped up a feasibility study with BaRupOn, exploring as much as 1 gigawatt of KRONOS power aimed at an AI data center and manufacturing hub in Texas.
NANO reported a net loss of $9.18 million, or 18 cents per share, for the quarter ended March 31. That’s narrower than the $21.31 million loss, or 57 cents a share, it posted in the same period last year. The company still hasn’t booked material revenue, per its latest quarterly filing.
Shares were changing hands around $27.54, up roughly 2%. That puts the company’s market cap near $1.37 billion. About 2.08 million shares traded so far. The stock touched lows of $25.76 and hit $29.60 on the high end earlier in the session.
Jay Yu, the company’s Founder and Chairman, described the KRONOS system as displaying a “high degree of design maturity.” The University of Illinois filing, Yu said, backs up the technology’s core credentials. He listed “regulatory advancement, commercial progress” and nuclear fuel-cycle integration among the potential drivers ahead. GlobeNewswire
Chief Executive James Walker told investors on the call the company expects the review to run about 12 months following formal NRC acceptance. NANO, he said, has already started discussions on licensing for the BaRupOn site. As for the Illinois application, Walker noted formal acceptance could arrive “anytime from today actually all the way through to early next week,” but flagged possible delays. Benzinga
The company is moving to align itself more with AI infrastructure. Earlier this month, it entered into a non-binding memorandum of understanding with Supermicro, aiming to explore how NANO microreactors might work alongside AI server and data center platforms—even considering off-grid setups.
The competition is heating up. Reuters reports Big Tech is throwing its weight behind advanced nuclear startups—TerraPower, Oklo, X-energy, Kairos Power—as the sector scrambles for steady power to feed data centers. In March, the NRC granted TerraPower a construction permit for its Kemmerer Power Station in Wyoming, signaling that other advanced reactor ventures are already pushing through regulatory gates.
The future here is hardly locked in. NANO’s filing spells out that its business model is still mostly unproven. It flags the need for potentially significant extra funding, and lists regulatory holdups, fuel sourcing, manufacturing limits and reliance on outside partners as possible hurdles. And for the record, a construction permit application isn’t the same thing as an operating license.
NANO’s balance sheet can handle extra spending, but dilution is still a live risk. The company confirmed its $900 million shelf registration is now in place, with a $400 million at-the-market program—essentially, authority to sell shares gradually as needed. CFO Jason Garcia told listeners on the call that none of the ATM capacity has been tapped so far, adding there’s no pressing need for new funds.
